Publications Maria Ulvmar

Publications in DiVA

Publications in PubMed

Selected publications:

  1. Bekkhus T, Avenel C, Hanna S, Franzén Boger M, Klemm A, Bacovia DV, Wärnberg F, Wählby C, Ulvmar MH. Automated detection of vascular remodeling in tumor-draining lymph nodes by the deep-learning tool HEV-finder. J Pathol. 2022, 258(1):4-11.
  2. Bekkhus T, Martikainen T, Olofsson A, Franzén Boger M, Vasiliu Bacovia D, Wärnberg F, Ulvmar MH. Remodeling of the Lymph Node High Endothelial Venules Reflects Tumor Invasiveness in Breast Cancer and is Associated with Dysregulation of Perivascular Stromal Cells. Cancers (Basel). 2021, 13(2):211. Selected for cover.
  3. Xiang M, Adrián Grosso R, Takeda A, Pan J, Bekkhus T, Brulois K, Dermadi D, Nordling S, Vanlandewijck M, Jalkanen S, Ulvmar MH.*, Butcher E.C.* A single-cell transcriptional roadmap of the mouse and human lymph node lymphatic vasculature. Frontiers in Cardiovascular medicine 2020, 2020, 7:52. *Delat sistaförfattarskap
  4. He Q, Li X, Singh K, Luo Z, Meija-Cordova M, Jamalpour M, Lindahl B, Kriz V, Vuolteenaho R, Ulvmar M, Welsh M. The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors. Scientific Reports, 2019, 9(1):7548.
  5. Zhang Y*, Ulvmar M.H*, Stanczuk L, Martinez-Corral I, Frye M, Mäkinen T. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms. Nature Communications, 2018, 9(1) 1226. *Delat förstaförfattarskap
  6. Nawaf MG, Ulvmar MH, Withers DR, McConnell FM, Gaspal FM, Jones ND, Yagita H, Allison JP, Lane PJL. Concurrent OX40 and CD30 Ligand blockade abrogates the CD4-driven autoimmunity associated with CTLA4 and PD1 blockade, while preserving excellent anti-CD8 tumor immunity. Journal of Immunology, 2017, 199(3):974-981.
  7. Ulvmar MH, Martínez-Corral I, Stanczuk L. Mäkinen T. Pdgfrb-Cre targets lymphatic endothelial cells of both venous and non-venous origins. Genesis, 2016, 54(6), 350-358.
  8. Ulvmar M.H. and Mäkinen T. Heterogeneity in the lymphatic vascular system and its origin Cardiovascular Research, 2016, 111(4): 310-321.
  9. Martínez-Corral I., Stanczuk L, Frye M, Ulvmar M, Dieguez-Hurtado R, Olmeda D, Mäkinen T, Ortega S. Vegfr3-CreERT2 mouse, a new genetic tool for targeting the lymphatic system. Angiogenesis, 2016, 19(3), 433-445.
  10. Lucas B, White AJ, Ulvmar MH, Nibbs R.J, Sitnik K.M. Agace W.W, Anderson G, Rot A. The atypical chemokine receptor CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. European Journal of Immunology, 2015, 45(2); 574-583.

Last modified: 2022-08-31